There are 2137 resources available
310P - Overall survival with cyclin-dependent kinase 4/6 inhibitors plus endocrine therapy in breast cancer: A meta-analysis of randomized controlled trials
Presenter: Qi Tian
Session: E-Poster Display
Resources:
Abstract
311P - Pooled-analysis of prospective observational studies evaluated the effectiveness and safety of bevacizumab and paclitaxel as the first-line chemotherapy for HER2-negative metastatic breast cancer
Presenter: Hiroyasu Yamashiro
Session: E-Poster Display
Resources:
Abstract
312P - Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2− advanced breast cancer (ABC)
Presenter: Reshma Mahtani
Session: E-Poster Display
Resources:
Abstract
313P - Real-world multi-country study of treatment trends among patients (pts) with HER2− BRCA1/2 mutated (BRCA1/2mut) advanced breast cancer (ABC)
Presenter: Reshma Mahtani
Session: E-Poster Display
Resources:
Abstract
314P - Real-world (RW) multi-country study of BRCA1/2 testing in adult patients (pts) with HER2−advanced breast cancer (ABC)
Presenter: Michael Patrick Lux
Session: E-Poster Display
Resources:
Abstract
315P - Trends in breast cancer mortality between 2001 and 2017: An observational study in EU and UK
Presenter: Chinmay Jani
Session: E-Poster Display
Resources:
Abstract
316P - Real-world treatment patterns and clinical effectiveness outcomes of eribulin in metastatic breast cancer patients in community oncology centers in the United States
Presenter: Sarah Mougalian
Session: E-Poster Display
Resources:
Abstract
317P - Updated results from the Canadian sub-population of the phase IIIb CompLEEment-1 ribociclib + letrozole HR+ HER2- advanced breast cancer trial
Presenter: Nadia Califaretti
Session: E-Poster Display
Resources:
Abstract
318P - The real-world Hellenic disease management patterns with everolimus (EVE) for women with hormone-receptor-positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer (aBC): ‘The MIRROR’ study
Presenter: Flora Zagouri
Session: E-Poster Display
Resources:
Abstract
319P - Prognosis for patients with oligometastatic breast cancer who achieve NED status after systemic and local therapy
Presenter: Ernesto Olcina Aguado
Session: E-Poster Display
Resources:
Abstract